Target intelligence / Profile preview

RN7SK pseudogene 22 (RN7SKP22)

Target
RN7SKP22
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene
01

Overview

RN7SK pseudogene 22 (RN7SKP22) is a processed pseudogene related to RN7SK, a small nuclear non-coding RNA involved in the regulation of transcription elongation by controlling the activity of positive transcription elongation factor b (P-TEFb)[3][1][2]. As a pseudogene, RN7SKP22 is generally believed to be non-functional and does not encode a protein or a functional RNA product. Its precise biological roles, if any, are not established, and it is not considered a therapeutic target. The functional importance described in the literature pertains to the parent gene RN7SK, not RN7SKP22. There is no evidence of RN7SKP22 acting as a receptor, enzyme, or being directly linked to any disease or therapeutic interventions[4][3].

Other names
RNA, 7SK small nuclear pseudogene 22RN7SKP22
02

Biological functions

Unknownlikely none (as a pseudogene)Related parent gene RN7SK is involved in transcriptional regulation and RNA processing
03

Disease associations

Other (no direct evidence; parent gene RN7SK may be associated with regulation in cancer and immune response, but not this pseudogene)

Beyond the preview

Go deeper on RN7SK pseudogene 22 (RN7SKP22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 22 (RN7SKP22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call